News

Gene Online News
geneonline. com > dcpep-rgp-fusion-vaccine-boosts-rabies-antibody-levels-in-mice

DCpep-RGP Fusion Vaccine Boosts Rabies Antibody Levels in Mice

43+ min ago  (184+ words) geneonline. com DCpep-RGP Fusion Vaccine Boosts Rabies Antibody Levels in Mice Researchers investigated a new approach to enhance the immune response to rabies vaccines by fusing the rabies virus glycoprotein (RGP) with a dendritic cell-targeting peptide (DCpep). The study aimed…...

Google News
geneonline. com > apixaban-shows-fewer-bleeding-complications-than-rivaroxaban-in-venous-thrombosis-trial

Apixaban Shows Fewer Bleeding Complications Than Rivaroxaban in Venous Thrombosis Trial - Gene Online News

1+ hour, 47+ min ago  (132+ words) Apixaban Shows Fewer Bleeding Complications Than Rivaroxaban in Venous Thrombosis Trial'geneonline. com Apixaban Shows Fewer Bleeding Complications Than Rivaroxaban in Venous Thrombosis Trial A recent clinical trial comparing apixaban and rivaroxaban, two frequently prescribed medications for venous thrombosis, revealed that…...

Google News
geneonline. com > study-documents-quantity-and-dimensions-of-vascular-microforamina-in-skull-linking-bone-to-brain-defense

Study Documents Quantity and Dimensions of Vascular Microforamina in Skull, Linking Bone to Brain Defense - Gene Online News

1+ hour, 54+ min ago  (161+ words) Study Documents Quantity and Dimensions of Vascular Microforamina in Skull, Linking Bone to Brain Defense'geneonline. com Study Documents Quantity and Dimensions of Vascular Microforamina in Skull, Linking Bone to Brain Defense A recent study has shed light on a network…...

Google News
geneonline. com > sparc-sells-rare-pediatric-disease-priority-review-voucher-for-195-million-after-sezaby-approval

SPARC Sells Rare Pediatric Disease Priority Review Voucher for $195 Million After Sezaby Approval - Gene Online News

1+ hour, 39+ min ago  (122+ words) SPARC Sells Rare Pediatric Disease Priority Review Voucher for $195 Million After Sezaby Approval'geneonline. com SPARC Sells Rare Pediatric Disease Priority Review Voucher for $195 Million After Sezaby Approval SPARC will sell a Rare Pediatric Disease Priority Review Voucher for $195 million through…...

Google News
geneonline. com > long-term-engagement-with-mental-health-services-common-after-first-psychiatric-admission-copenhagen-study-follows-150-individuals-for-20-years

Long-Term Engagement with Mental Health Services Common After First Psychiatric Admission: Copenhagen Study Follows 150 Individuals for 20 Years - Gene Online News

1+ hour, 54+ min ago  (140+ words) Long-Term Engagement with Mental Health Services Common After First Psychiatric Admission: Copenhagen Study Follows 150 Individuals for 20 Years'geneonline. com Long-Term Engagement with Mental Health Services Common After First Psychiatric Admission: Copenhagen Study Follows 150 Individuals for 20 Years A recent study indicates that…...

Gene Online News
geneonline. com > rise-in-bowel-and-ovarian-cancer-cases-among-adults-under-50-observed-in-england-study

Rise in Bowel and Ovarian Cancer Cases Among Adults Under 50 Observed in England Study

4+ day, 12+ hour ago  (16+ words) geneonline. com...

Gene Online News
geneonline. com > european-commission-approves-poherdy-as-first-biosimilar-to-perjeta-for-her2-positive-breast-cancer

European Commission Approves POHERDY as First Biosimilar to PERJETA for HER2-Positive Breast Cancer

4+ day, 3+ hour ago  (161+ words) geneonline. com European Commission Approves POHERDY as First Biosimilar to PERJETA for HER2-Positive Breast Cancer The European Commission has granted marketing authorization for POHERDY" (pertuzumab), a biosimilar jointly developed by Henlius and Organon. This marks the first approval of a…...

Gene Online News
geneonline. com > public-interest-capital-george-haras-blueprint-for-scaling-technology-biotech-and-the-middle-class

Public Interest Capital: George Hara's Blueprint for Scaling Technology, Biotech, and the Middle Class

5+ day, 4+ hour ago  (790+ words) If done correctly, he argued, the result is not only financial success, but the reconstruction of a healthy middle class through technology-led economic growth. Hara began by identifying what he sees as one of the world's most pressing economic risks:…...

Gene Online News
geneonline. com > medtec-japan-2026-seminar-program-maps-global-regulatory-shifts-and-digital-transformation-pathways-for-medical-device-industry-007conference

Medtec Japan 2026 Seminar Program Maps Global Regulatory Shifts and Digital Transformation Pathways for Medical Device Industry

1+ week, 2+ day ago  (636+ words) geneonline. com Medtec Japan 2026 Seminar Program Maps Global Regulatory Shifts and Digital Transformation Pathways for Medical Device Industry Medtec Japan 2026 outlines a comprehensive seminar topics accross from April 21 through 23 at Tokyo Big Sight. Organized as part of the premier medical…...